Business
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology.
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology\nCanada NewsWire\nOTTAWA, ON, May 10, 2022\n\n\n\nPanag Pharma Inc (Panag), a subsidiary of Tetra Bio-Pharma, will collect royalties on sales on products produced with the technology True North has licensed from Panag.Use of a highly innovative proprietary liposome encapsulated technology leads to a better CBD absorption.This New True North Nectar product line in liquid and powder formats are expected to launch in select markets in Q4 2022.OTTAWA, ON, May 10, 2022 /CNW/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Company\") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development in collaboration with Panag, a subsidiary of Tetra Bio-Pharma, and True North Cannabis Corp (True North), today announced it has entered into a technology licensing agreement allowing True North to use its highly innovative proprietary liposome encapsulated technology within formulations distributed under the True North brand.\n\n \n \n \n \n \n \n\n \nTetra's patented technology leads to better absorption and aqueous emulsification of the CBD molecule in a variety of products. Panag will work with True North's product team to integrate this technology and develop a line of hemp-derived CBD formulations, for True North and its partners to commercialize through their existing distribution relationships in both the medical and recreational markets in Canada\nAbout the TechnologyIn developing these products, the Panag team is using Tetra's liposome encapsulated technology, a patented process to encapsulate and protect the active molecules into a multi-layered sphere. Delivery of the formulation is greatly improved by enhancing the dispersion of loaded liposomal spheres within an aqueous (water-based) environment.\n\"This opportunity is the beginning of a great relationship between the two companies. Panag has enj...